Abdulkareem , I.H., 2013.A review on pathogenesis of breast cancer,J. Genet. Syndr. Genet. Ther 4 1 -4
ACA (American CancerSociety).,GA, 2016.Breast Cancer Diagnosis. American Cancer Society Inc, -
ACA (American CancerSociety).,GA, 2016.Cancer Facts and Figures. American Cancer Society Inc, -
Arteaga , C.L.,M.X.Sliwkowski,C.K.Osborne,E.A.Perez,F.Puglisi,L.Gianni, 2012.Treatment of HER2-positive breast cancer: current status and future perspectives,Nat. Rev. Clin. Oncol 9 16 -32
Casimiro , M.C.,M. Crosariol , E.,Loro , Z.,Li and R.G.,Pestell, 2013.Cyclins and cell cycle control in cancer and disease,Genes Cancer 3 649 -657
Danaei, 2016.BREAST CANCER STATISTICS WORLDWIDE,Accessed on: 8 July -
Dowsett , M., T.O.,Nielsen , J.,Bartlett , R. C.,Coombes , J.,Cuzick , M.,Ellis , J.C.,Hugh and D.F.,Hayes, 2011.Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group,J Natl. Cancer Inst 103 1 -9
Felix , G.E.S.,C.A.Sandes,R.S.C.Guindalini,L.Nascimento,K.A.Sandes, 2014.Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population,Human Genome Variation 10 -
Hayatin , D.K., 2016.-incidence-of-breast-cancer-in-asia/,Accessed on: 7 July -
Hosoda , M.,M.Yamamoto,K.Nakano,K.C.Hatanaka,E.Takakuwa,Y.Hatanaka, 2014.Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer,Breast Cancer Res. Treat 144 249 -261
IHME, 2016.New cancer cases rise globally, but death rates are declining in many countries,Institute for Health Metrics and Evaluation -
Kim , E.J.,M.R.Choi,H.Park,M.Kim,J.E.Hong,K.W.Lee,J.H.Y.Park, 2011.Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice,Breast Cancer Res. Treat 13 R78 -
Kim , J., S.D.,Lee , B.,Chang , D.H.,Jin , S.,Jung , M.Y.,Park , Y. Han and M.S.,Lee, 2012.Enhanced antitumor activity of vitamin C via p53 in cancer cells,Free Radic. Biol. Med 53 1607 -1615
Langosch , K.,T.Karn,V.Muller,I. Witzel,A.Rody,M.Schmidt,R.M.Wirtz, 2012.Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer,Breast Can. Res Treat 137 57 -67
Ledesma , N., 2015.Nutrition and Breast Cancer, -
Lee , D.S., S.H.,Kim , Y.J.,Suh , S.,Kim , H.K.,Kim and B.Y.,Shim, 2011.Clinical implication of p53 overexpression in breast cancer patients younger than 50 years with a triple-negative subtype who undergo a modified radical mastectomy,Jap. J. Clin. Oncol 41 854 -66
Manna , S. , S.,Mukherjee , A.,Roy , S.,Das and C.K.,Panda, 2009.Tea polyphenols can restrict carcinogenesis by altered expression of p53- associated genes and H-ras, c-myc and cyclin D1,J. Nutr. Bio 20 337 -349
Misek , D.E.,E.H.Kim, 2011.Protein biomarkers for the early detection of breast cancer,Int. J. Proteom. -
NCI (National CancerInstitute)., 2015.NCI dictionary of cancer terms,National Cancer Institute -
SKMCH (Shaukat Khanum Memorial Cancer Hospital), 2016.Breast cancer,Accessed on: February 18 -
WHO, 2013.Breast Cancer Burden, -
WHO, 2014.Breast Cancer,World Health Organization. Geneva -
Yasmeen , F. and S.,Zaheer, 2014.Functional time series models to estimate future age-specific breast cancer incidence rates for women in Karachi, Pakistan,J. Health Sci 2 213 -221